Cost Effectiveness [qnco]
rosuvastatin [orch, phsu]
EZETIMIBE/SIMVASTATIN [orch, phsu]
Managing [ocac]
Dyslipidaemia [dsyn]
Patients [podg]
Mexico [geoa]
Objective [inpr]
Purpose [ftcn]
Study [mnob]
Effectiveness [qlco]
Cost Effectiveness [qnco]
Oral [spco]
rosuvastatin [orch, phsu]
mg day [qnco]
Oral [spco]
ezetimibe 10 MG [clnd]
Simvastatin [orch, phsu]
Patients [podg]
Meet [idcn]
Goals [inpr]
Set [menp]
Out [spco]
national [inpr]
Cholesterol [bacs, strd]
educational program [edac]
Adult [aggp]
treatment [ftcn]
Panel [idcn]
III [inpr]
Guidelines [inpr]
Percent [qnco]
Atherogenesis [patf]
Lipid [lipd]
Profile [lbpr]
Daily [tmco]
Out-patient [podg]
practice [menp]
Specialty [bmod]
Hospital [hcro, mnob]
Mexico [geoa]
City [geoa]
Methods [inpr]
Out-patient [podg]
Medical Records [inpr]
Cardiology service [topp]
reviewed [inpr]
Following [tmco]
criteria [inpr]
Established diagnosis [qlco]
Dyslipidaemia [dsyn]
Triglycerides [bacs, lipd]
serum lipid [lbpr]
measurements [ftcn]
TC [geoa]
Taken [cnce]
Receive [qlco]
Drug Therapy [topp]
Oral [spco]
rosuvastatin [orch, phsu]
mg day [qnco]
Oral [spco]
ezetimibe 10 MG [clnd]
Simvastatin [orch, phsu]
Daily [tmco]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
Administered [ftcn]
Lipid level [lbtr]
Record [inpr]
weeks [tmco]
treatment [ftcn]
Cost Analysis [ocac]
Performed [ftcn]
Institution [hcro, mnob]
exchange rate [qnco]
dollar [qnco]
determinism [idcn]
Performed [ftcn]
Treatment Costs [qnco]
Proportion [qnco]
Patients [podg]
Adult [aggp]
treatment [ftcn]
Panel [idcn]
III [inpr]
Goal [inpr]
Percentage [qnco]
Decrease [qlco]
Addition [ftcn]
Performed [ftcn]
Uncertainty [idcn]
estimations [menp]
Cost [qnco]
Effectiveness [qlco]
estimations [menp]
Adult [aggp]
treatment [ftcn]
Panel [idcn]
III [inpr]
criteria [inpr]
Percentage [qnco]
Patients [podg]
Reach [orgf]
Goals [inpr]
Patients [podg]
Received [qlco]
rosuvastatin [orch, phsu]
Proportion [qnco]
Patients [podg]
Received [qlco]
EZETIMIBE/SIMVASTATIN [orch, phsu]
P NOS [aapp, imft]
Adult [aggp]
treatment [ftcn]
Panel [idcn]
III [inpr]
criteria [inpr]
rosuvastatin [orch, phsu]
EZETIMIBE/SIMVASTATIN [orch, phsu]
P NOS [aapp, imft]
Cost [qnco]
reduction [npop]
rosuvastatin [orch, phsu]
EZETIMIBE/SIMVASTATIN [orch, phsu]
Cost Effectiveness [qnco]
acceptability [qlco]
Curve [spco]
rosuvastatin [orch, phsu]
Cost Effectiveness [qnco]
EZETIMIBE/SIMVASTATIN [orch, phsu]
Based [ftcn]
Patients [podg]
Goals [inpr]
Conclusions [idcn]
Controlled [ftcn]
retrospective [resa]
Daily [tmco]
practice [menp]
High Risk [qlco]
CARDIOVASCULAR [bdsy]
Mexican [popg]
Patients [podg]
treatment [ftcn]
Oral [spco]
rosuvastatin [orch, phsu]
mg day [qnco]
effective [qlco]
treatment [ftcn]
Fixed [fndg]
Combination [qlco]
Oral [spco]
ezetimibe 10 MG [clnd]
Simvastatin [orch, phsu]
